|
LifeSciences British Columbia Adds Three Industry Leaders to their Board of Directors September 25, 2008 For Immediate Release – September 24, 2008 Vancouver – LifeSciences BC today announced the appointment of three new Board members representing leading life sciences companies in British Columbia. Mr. Ian Thompson, President, Canadian BioEnergy was appointed as of the September 16th Board of Directors’ meeting, and Dr. Steven Gillis, Managing Director, ARCH Venture Partners; and Mr. Gordon MacCauley, President & Chief Executive Officer, Allon Therapeutics were elected to LifeSciences BC’s Board of Directors at yesterday’s Annual General Meeting. Dr. Robert Sindelar of UBC was also re-elected to the Board of Directors. Read more Tekmira Pharmaceuticals Expands Executive Management Team VANCOUVER, BC, Canada | Posted on September 29th, 2008 Dr. Mark J. Murray, Tekmira's President and CEO, said, "We are extremely pleased to add Tammy and Peter to our executive management team as each bring significant experience in their respective fields. These appointments further support our corporate priorities of advancing proprietary siRNA product candidates and licensing our leading RNAi technology to the pharmaceutical industry." Tammy Mullarky has joined Tekmira effective immediately and will have responsibility for strategic planning and business development including securing additional licensing and collaborative research and development agreements for Tekmira's technology. Ms. Mullarky joined Tekmira from Targeted Growth, Inc. where as Senior Vice President she was responsible for business functions including business development, intellectual property and finance. Prior to Targeted Growth, Ms. Mullarky was a senior executive at Epigenomics, AG where she completed a $100 million diagnostics partnership. Ms. Mullarky also has experience as a venture capital partner and was a founder and senior executive at AnorMed Inc. Before AnorMed, she was a member of the corporate mergers and acquisitions team for F. Hoffmann-La Roche. Ms. Mullarky has a M.A. in Science Management from the Massachusetts Institute of Technology and a B.A. in Chemistry from Whitman College. Dr. Lutwyche joined Tekmira's subsidiary company, Protiva Biotherapeutics Inc., in February 2008, and has responsibility for manufacturing, process development and quality control for all Tekmira product candidates as well as supporting Tekmira's collaborative partners as they advance products based on Tekmira's technology. Tekmira expects three siRNA product candidates using the company's SNALP delivery technology will be in clinical development in 2009. Dr. Lutwyche joined Tekmira from QLT Inc., where he was employed for ten years, most recently as Director, Pharmaceutical Development. During his tenure at QLT, Dr. Lutwyche contributed to the development and commercialization of Visudyne as well as leading manufacturing and chemistry efforts for numerous preclinical and clinical stage products. Prior to QLT, he was a research scientist at Inex Pharmaceuticals Corporation working with lipid-based formulations of nucleic acids and antibiotics. Dr. Lutwyche holds a Ph.D. in Chemistry from the University of British Columbia. Zymeworks Appoints Dr. Richard Lavery to its Scientific Advisory Board Urodynamix Appoints Chief Financial Officer November 03, 2008 VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 3, 2008) - Urodynamix Technologies Ltd., ("Urodynamix") (TSX VENTURE:URO) today announced the appointment of Jonathan Jackson, CA as Chief Financial Officer. Mr. Jackson has held CFO and VP Finance roles in high-tech and manufacturing companies for the past 12 years and was most recently the Chief Financial Officer at Extreme CCTV Inc., where he successfully completed the sale of that company to Robert Bosch GmbH of Germany. Mr. Jackson has a Bachelor of Commerce degree from the University of Saskatchewan and is a member of the Institute of Chartered Accountants of British Columbia. Read more FARRIS WELCOMES DAVID EMERSON AS SENIOR ADVISOR November 17, 2008 VANCOUVER - Farris, Vaughan, Wills & Murphy LLP (Farris), one of Canada’s leading law firms, today welcomes The Honourable David Emerson, P.C., formerly Canada’s Minister of Foreign Affairs, to the firm as Senior Advisor. Farris Chair Keith Mitchell, Q.C., said today, “Mr. Emerson is one of Canada’s outstanding leaders in both the public and private sectors. We are honoured and delighted he has decided to join Farris.” “Mr. Emerson, having served in leadership roles nationally with Prime Minister Stephen Harper and Prime Minister Paul Martin and provincially with Premiers Barrett, Bennett, Vander Zalm, Harcourt and Campbell, brings exceptional expertise and insight to our firm and its clients”, noted Alan Hamilton, Q.C., Managing Partner. Mr. Emerson said, “I am looking forward to working with Farris, a British Columbia-based firm with a national perspective. I am pleased to join this team and share in their focus on assisting their clients in meeting the practical demands and opportunities of today, provincially, nationally and internationally.” Mr. Emerson obtained his Doctorate in Economics from Queens University. Nationally he has held senior positions that include Minister of Foreign Affairs, Minister of Industry, Minister of International Trade and Minister for Pacific Gateway and Vancouver – Whistler Olympics. In British Columbia he was the Province’s Deputy Minister of Finance, Deputy Minister to the Premier and later President of the British Columbia Trade Development Corporation. He has also served in leadership roles in the private sector, including as President and CEO of Canfor Corporation, the first President and CEO of the Vancouver International Airport Authority and Chairman and CEO of Canadian Western Bank. Mr. Emerson has been deeply involved in economic policy, globalization and trade policy and public/private partnerships. ABOUT FARRIS Farris is a leading Canadian law firm with offices in Vancouver, Kelowna and Victoria, British Columbia. It has a diverse client base that includes some of the largest public institutions and private corporations in the province. Founded in 1903 by Senator John Farris, Farris provides innovative solutions, expertise and experience in the areas of corporate law, litigation, labour and employment law and taxation. Many Farris lawyers are ranked among The Top 500 Lawyers in Canada by Lexpert, the most respected legal publication in Canada. To learn more, please visit our website at www.farris.com or see Emerson Joins Farris. |
 Suite 900 - 1188 West Georgia St.
Vancouver, BC V6E 4A2 |